Cedar Mountain Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3K Hold
96
﹤0.01% 912
2026
Q1
$575 Sell
96
-1
-1% -$8 ﹤0.01% 996
2025
Q4
$695 Buy
97
+47
+94% +$371 ﹤0.01% 565
2025
Q3
$534 Buy
+50
New +$491 ﹤0.01% 596
2024
Q3
Sell
-6
Closed -$124 350
2024
Q2
$124 Buy
6
+4
+200% +$79 ﹤0.01% 329
2024
Q1
$38 Buy
+2
New +$34 ﹤0.01% 341
2022
Q4
Sell
-13
Closed 319
2022
Q3
$0 Buy
13
+1
+8% +$30 ﹤0.01% 318
2022
Q2
$0 Buy
+12
New +$420 ﹤0.01% 329
2022
Q1
Sell
-12
Closed 334
2021
Q4
$0 Hold
12
﹤0.01% 321
2021
Q3
$0 Hold
12
﹤0.01% 304
2021
Q2
$0 Buy
+12
New +$395 ﹤0.01% 287

Other funds holding OGN

Cedar Mountain Advisors's OGN Position: Q2 2026 in Review

Cedar Mountain Advisors held its Organon & Co (OGN) position steady in Q2 2026 at 96 shares worth $1.3K. The position accounts for ﹤0.01% of the portfolio, ranked #912.

Cedar Mountain Advisors first reported a position in OGN in Q2 2021 and has held it in 11 quarters since. 79 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Cedar Mountain Advisors held 96 shares of Organon & Co worth $1.3K as of Q2 2026.
  • Cedar Mountain Advisors left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #912 holding.
  • Cedar Mountain Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 11 quarters since.
  • 79 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.